Newsroom

All News
  • All News
  • In the News
  • Press Releases
  • Publications
  • Events
  • Noteworthy Articles
ICICEM small

Sepsis: 2026

A plenary lecture that took a journey through how we may treat sepsis in 10 years was featured with Steven Opal (Rhode Island Hospital, Providence, RI, USA) stepping up to speak about the expectations, hopes and remaining challenges in the field.
ICICEM small

36th International Symposium on Intensive Care and Emergency Medicine

36th International Symposium on Intensive Care and Emergency Medicine March 15-18, 2016 Brussels, Belgium. Russ Miller, of Intermountain Healthcare presented data on the market need for accurate sepsis diagnostics using results from the IXP VENUS trial showing that expert physicians agree on a diagnosis of sepsis in between 60 to...
Immunexpress.com

Immunexpress Presents on the Need for an Objective Diagnostic Tool for Systemic Inflammation at the International Symposium on Intensive Care and Emergency Medicine

Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced the presentation of data from the VENUS trial by Dr. Bert Lopansri of Intermountain Medical Center at the 36th International Symposium on Intensive Care and Emergency Medicine in Brussels, Belgium. The presentation describes the...
PSBJ-logo-550x455

Seattle biotech Immunexpress eyes up to $40M for Series C round

Seattle biotech Immunexpress is trying to raise up to $40 million in a Series C round that it plans to close by mid-year. By Rachel Nielsen.
Immunexpress.com

Immunexpress Announces Presentation at the 36th International Symposium on Intensive Care and Emergency Medicine on the Need for an Objective Diagnostic Tool for Systemic Inflammation

Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced that data from the VENUS trial showing the discordance between clinical impressions of patients with systemic inflammation will be presented at the upcoming 36th International Symposium on Intensive Care and Emergency Medicine on Mar....
Immunexpress.com

Immunexpress Presents Results Indicating the Utility of SeptiCyte™ for the Diagnosis of Sepsis in Critically Ill Children at the 45th Annual Society of Critical Care Medicine Congress

Additional Results from the VENUS A Study Further Validate SeptiCyte as a Diagnostic Assay for Sepsis in Critically Ill Adults SEATTLE, Feb. 22, 2016 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced the presentation of data on the utility of SeptiCyte™...
Immunexpress.com

Immunexpress Announces Presentations at the 45th Annual Society of Critical Care Medicine Congress on the Utility of SeptiCyte™ LAB

SEATTLE, Feb. 10, 2016 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced that data on the utility of SeptiCyte® Lab in both adult and pediatric populations to aid in the clinical assessment of sepsis in critical care patients will be presented...
healtheo360 large

An Interview With Roslyn Brandon from Immunexpress

Dave sits down with Roslyn Brandon from Immunexpress at the JP Morgan Annual Health Conference. In this interview, they discuss the problems of diagnosing sepsis and their innovative solution with SeptiCyte.
healtheo360 large

An Interview With Roy Davis from Immunexpress

Dave sits down with Roy Davis from Immunexpress while at the JP Morgan Annual Health Conference. In this video, they discuss a new diagnostic test for detecting sepsis in patients.
pmwc-logo

Personalized Medicine World Conference

Personalized Medicine World Conference January 24-27, 2016 Silicon Valley, CA. Invited talk by Leo McHugh on host response transcriptomics for the diagnosis and management on critical infections. Presented results of various SeptiCyte™ validation trials and in-silico analyses for other clinical management related gene expression signatures.
genome web

Immunexpress, Collaborators Publish Clinical Validation of Host-Response Sepsis Assay

Immunexpress, Inc., committed to improving outcomes for suspected sepsis patients, announced the publication of the discovery and validation of the SeptiCyte® Lab test for sepsis in PLOS Medicine.
Plos-medicine (1)

A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts

McHugh et al., PLOS Medicine | SeptiCyte Lab is a rapid molecular assay that may be clinically useful in managing ICU patients with systemic inflammation. Further study in population-based cohorts is needed to validate this assay for clinical use.

If you are a member of the media, please contact:

Scott Stachowiak
Russo Partners
(646) 942-5630
scott.stachowiak@russopartnersllc.com